Home
News
299
Results found
-
A big “Welcome!” to our new colleagues
We are happy to welcome Daniela, Bianca, Jacqueline and Robin who joined Lygature since the start of 2020! Below you can meet them and get to know more about their work in our team. -
BBMRI.nl celebrates 10 years of its existence
10 years ago BBMRI.nl started building the joint national infrastructure necessary to make maximal use of biosamples, images and data for health research. -
MOMENTUM study reaches 500-patient milestone
MOMENTUM, a study focused on tracking the outcomes of combining Magnetic Resonance (MR) and Radiation Therapy (RT) to treat common types of cancer, has successfully enrolled 500 patients – an impressive milestone to have reached in just over a year, across seven collaborating institutions in four countries. -
2020 Health-RI conference
More than 400 health innovators, academic researchers, health care professionals, IT-specialists, and patients representatives, industry and policy gathered in Utrecht on January 30 for the 2020 Health-RI Conference ‘Towards Data Driven Health.’ -
Personal Health Train now departs from its own platform
At a sold-out Health-RI conference, the Dutch secretary-general of the Ministry of Health officially launched the Personal Health Train network platform. It marked the official start of the PHT network, a community-effort to advance the analysis of health data from various sources, in a safe, efficient and responsible way. -
Health Innovation Netherlands officially launched: Infrastructure to faster deliver better medical devices
Health Innovation Netherlands was officially launched during the "Werkconferentie Nationale Medtech Agenda 2020-2025" at the Dutch Ministry of Health. -
Lygature supports World Neglected Tropical Diseases Day
This Thursday, 30 January, marks the inaugural World Neglected Tropical Diseases (NTD) Day, an initiative designed to draw attention to priority issues surrounding NTDs and the efforts being made to combat them. -
Improvements needed in recording brand and batch numbers for biological medicines to ensure patient safety
Health professionals need to improve how they record brand and batch numbers for biologic medicines to ensure patients stay safe, according to a new study carried out by Kevin Klein and Pieter Stolk from Lygature, and Lorna Hazell and Saad Shakir from UK’s Drug Safety Research Unit (DSRU). -
Patient engagement: how end-users can help you develop better medical products
In this series of articles, we look back at the highlights of the parallel sessions that were organized at the 2019 Lygature Partnerships Meetup. -
PM2019 session: The path to open science
In this series of articles, we look back at the highlights of the parallel sessions that were organized at the 2019 Lygature Partnerships Meetup. -
Parallel session “Next-generation leads targeting neglected tropical diseases”
In this series of articles, we look back at the highlights of the parallel sessions that were organized at the 2019 Lygature Partnerships Meetup. -
PM2019 session: Successful integration of ethics and integrity in partnerships – a joint responsibility
In this series of articles, we look back at the highlights of the sessions that were organized at this year’s Lygature Partnerships Meetup. -
Patient engagement and personalized health care at the EPF congress
Irene Kanter-Schlifke, Program Manager at Lygature, attended the annual congress of the European Patients´ Forum (EPF) on advancing meaningful patient involvement. In this blog, Irene shares her main insights on the event. -
PM2019 session: Artificial Intelligence in medicine development - without the hot air
In this series of articles, we look back at the highlights of the parallel sessions that were organized at this year’s Lygature Partnerships Meetup -
Regulations for complex drug products; is global alignment in sight?
Jon de Vlieger, Director of Business Development and Coordinator of the Non-Biological Complex Drugs (NBCD) Working Group at Lygature, was invited to present at two high-profile international meetings, where he shared his views on regulations for complex drug products. Read more in his blog below.